Correction

Published on 12 Aug 2024

Corrigendum: Analysis of factors associated with positive surgical margins and the five-year survival rate after prostate cancer resection and predictive modeling

in Cancer Cell Signaling

Kai Li
Yantao Zhang
Sinan Tian
Qingguo Su
Yanhui Mei
Wei Shi
Jingyuan Cao
Lijuan Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1469673

465 views

Review

Published on 15 Jul 2024

Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics

in Cancer Cell Signaling

Anjana Sajeev
Bandari BharathwajChetty
Mukesh Kumar Manickasamy
Mohammed S. Alqahtani
Mohamed Abbas
Mehdi Shakibaei
Gautam Sethi
Zhaowu Ma
Ajaikumar B. Kunnumakkara

Frontiers in Oncology

doi 10.3389/fonc.2024.1383939

1,218 views
1 citation

Review

Published on 08 Jul 2024

Fibroblast growth factor receptor signaling in estrogen receptor-positive breast cancer: mechanisms and role in endocrine resistance

in Cancer Cell Signaling

Arnaldo Marin
Fernanda Morales
Benjamín Walbaum

Frontiers in Oncology

doi 10.3389/fonc.2024.1406951

2,240 views

Review

Published on 14 Jun 2024

The dual role of sirtuins in cancer: biological functions and implications

in Cancer Cell Signaling

Lu Yu
Yanjiao Li
Siyuan Song
Yalin Zhang
Yiping Wang
Hailian Wang
Zhengteng Yang
Yi Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1384928

1,770 views
3 citations

Review

Published on 07 Jun 2024

Wnt signaling in gastric cancer: current progress and future prospects

in Cancer Cell Signaling

Ruyue Han
Jing Yang
Yingying Zhu
Runliang Gan

Frontiers in Oncology

doi 10.3389/fonc.2024.1410513

1,202 views

Original Research

Published on 06 Jun 2024

Analysis of factors associated with positive surgical margins and the five-year survival rate after prostate cancer resection and predictive modeling

in Cancer Cell Signaling

Kai Li
Yantao Zhang
Sinan Tian
Qingguo Su
Yanhui Mei
Wei Shi
Jingyuan Cao
Lijuan Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1360404

896 views

Original Research

Published on 16 May 2024

Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition

in Cancer Cell Signaling

Evan DuBose
Samantha M. Bevill
Dana K. Mitchell
Noah Sciaky
Brian T. Golitz
Shelley A. H. Dixon
Steven D. Rhodes
James E. Bear
Gary L. Johnson
Steven P. Angus

Frontiers in Oncology

doi 10.3389/fonc.2024.1191217

1,655 views

Systematic Review

Published on 01 May 2024

Association of future cancer metastases with fibroblast activation protein-α: a systematic review and meta-analysis

in Cancer Cell Signaling

Majid Janani
Amirhoushang Poorkhani
Taghi Amiriani
Ghazaleh Donyadideh
Farahnazsadat Ahmadi
Yalda Jorjanisorkhankalateh
Fereshteh Beheshti-Nia
Zahra Kalaei
Morad Roudbaraki
Mahsa Soltani

Frontiers in Oncology

doi 10.3389/fonc.2024.1339050

1,207 views
1 citation

Mini Review

Published on 26 Apr 2024

Purinosomes involved in the regulation of tumor metabolism: current progress and potential application targets

in Cancer Cell Signaling

Jiaqi Xie
Jiaqi Liu
Xiehui Chen
Changchun Zeng

Frontiers in Oncology

doi 10.3389/fonc.2024.1333822

1,274 views

Review

Published on 15 Apr 2024

Role of SPRY4 in health and disease

in Cancer Cell Signaling

Hao Pan
Renjie Xu
Yong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1376873

2,394 views
1 citation

Review

Published on 05 Apr 2024

Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target

in Cancer Cell Signaling

Binbin Hu
Guihong Liu
Kejia Zhao
Gao Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1388999

2,321 views
3 citations

Review

Published on 02 Apr 2024

Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target

in Cancer Cell Signaling

Zekun Zhao
Tenglu Cui
Fengxian Wei
Zhiming Zhou
Yuan Sun
Chaofeng Gao
Xiaodong Xu
Huihan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1367364

2,659 views
5 citations

Review

Published on 27 Sep 2023

Dual mechanism of Let-7i in tumor progression

in Cancer Cell Signaling

Jiapei Zhou
Hongjie Xiang
Zhiqun Cao

Frontiers in Oncology

doi 10.3389/fonc.2023.1253191

2,357 views
2 citations

Review

Published on 11 Sep 2023

EGFR trafficking: effect of dimerization, dynamics, and mutation

in Cancer Cell Signaling

Destiny F. Schultz
Daniel D. Billadeau
Seetharama D. Jois

Frontiers in Oncology

doi 10.3389/fonc.2023.1258371

4,263 views
6 citations

Review

Published on 27 Jul 2023

Emerging roles of PHLPP phosphatases in lung cancer

in Cancer Cell Signaling

Xinhang Xia
Wenhu Pi
Meng Chen
Wei Wang
Danyang Cai
Xuequan Wang
Yanli Lan
Haihua Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1216131

3,140 views
1 citation

Review

Published on 26 Apr 2023

An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?

in Cancer Cell Signaling

Milan Teraiya
Helene Perreault
Vincent C. Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1166207

9,145 views
14 citations

Navigation group

Articles

Corrigendum: Analysis of factors associated with positive surgical margins and the five-year survival rate after prostate cancer resection and predictive modeling

Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics

Fibroblast growth factor receptor signaling in estrogen receptor-positive breast cancer: mechanisms and role in endocrine resistance

The dual role of sirtuins in cancer: biological functions and implications

Wnt signaling in gastric cancer: current progress and future prospects

Analysis of factors associated with positive surgical margins and the five-year survival rate after prostate cancer resection and predictive modeling

Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition

Association of future cancer metastases with fibroblast activation protein-α: a systematic review and meta-analysis

Purinosomes involved in the regulation of tumor metabolism: current progress and potential application targets

Role of SPRY4 in health and disease

Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target

Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target

Dual mechanism of Let-7i in tumor progression

EGFR trafficking: effect of dimerization, dynamics, and mutation

Emerging roles of PHLPP phosphatases in lung cancer

An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?